Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2022 10:00 ET | Source: Coloplast A/S

Coloplast awarded AscenDrive Agreement for Ostomy Products with Premier, Inc.

Coloplast, a global medical device company and leader in intimate healthcare needs, has been awarded an AscenDrive agreement with Premier, Inc. AscenDrive is a national program designed to standardize...
May 17, 2022 04:30 ET | Source: Coloplast A/S

Nueva web informative sobre la cirugía del cancer de laringe

Zonalaringectomia.com es una fuente completa de información sobre la laringectomía total Atos Medical, una empresa líder en el cuidado de la laringectomía y parte de Coloplast A/S, anunció...
May 17, 2022 04:30 ET | Source: Coloplast A/S

Nouveau site internet d’informations sur la chirurgie du cancer du larynx

Laryngectomie.info est une source d’informations complète sur la laryngectomie totale Atos Medical, société leader dans le domaine des soins de la laryngectomie et faisant partie de Coloplast...
May 17, 2022 04:30 ET | Source: Coloplast A/S

New informational website around larynx cancer surgery

Laryngectomy.info is a comprehensive source of information on total laryngectomy Atos Medical, a leading company in laryngectomy care and part of Coloplast A/S, announced today that they are...
May 11, 2022 12:54 ET | Source: Coloplast A/S

Selskabsmeddelelse nr. 06/2022 - Coloplast offentliggør obligationsudstedelse på EUR 2,2 mia. som led i selskabets Euro Medium Term Note-program

Coloplast offentliggør obligationsudstedelse på EUR 2,2 mia. som led i selskabets Euro Medium Term Note-program MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES DIREKTE ELLER INDIREKTE I USA....
May 11, 2022 12:54 ET | Source: Coloplast A/S

Announcement no. 06/2022 - Coloplast announces the successful issuance of EUR 2.2 billion senior notes under its Euro Medium Term Note programme

Coloplast announces the successful issuance of EUR 2.2 billion senior notes under its Euro Medium Term Note programme NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR...
May 09, 2022 04:46 ET | Source: Coloplast A/S

Selskabsmeddelelse nr. 05/2022 - Coloplast offentliggør etableringen af selskabets Euro Medium Term Note-program

MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES DIREKTE ELLER INDIREKTE I USA. MÅ IKKE UDGIVES, OFFENTLIGGØRES ELLER DISTRIBUERES DIREKTE ELLER INDIREKTE TIL PERSONER I NOGEN JURISDIKTION, HVOR DER...
May 09, 2022 04:46 ET | Source: Coloplast A/S

Announcement no. 05/2022 - Coloplast announces the establishment of its Euro Medium Term Note programme

NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY...
May 05, 2022 06:05 ET | Source: Coloplast A/S

Coloplast leverer solidt 2. kvartal med 7% organisk vækst og en overskudsgrad på 31% og justerer forventningerne til den organiske vækst for 2021/22 til 6-7% fra omkring 7%

Forventningerne til den rapporterede vækst og den rapporterede overskudsgrad før særlige poster fastholdes på hhv. omkring 15% og omkring 31%. Den rapporterede omsætning målt i danske kroner steg 16%...
May 05, 2022 06:05 ET | Source: Coloplast A/S

Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin and revises full year organic growth guidance to 6-7% from around 7%

The company maintains its reported growth guidance of around 15% and reported EBIT margin guidance of around 31% before special items. Reported revenue in DKK was up by 16% in Q2. EBIT before special...